IDOVEN

About:

Re-defining the way cardiovascular diseases are detected with Artificial Intelligence (AI)

Website: https://idoven.ai/

Twitter/X: Idoven_ai

Top Investors: Google for Startups, European Innovation Council, Accel, Insight Partners, Wayra

Description:

Idoven has developed the world’s first cardiology-as-a-service platform powered by artificial intelligence that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale. The company counts partners such as AstraZeneca, Abbott, and GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation. Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. CB Insights have also selected Idoven as one of the top 50 companies in Digital Health for 2023

Total Funding Amount:

22.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madrid, Madrid, Spain

Founded Date:

2018-05-31

Contact Email:

contact(AT)idoven.ai

Founders:

Inigo Juantegui, José María Lillo Castellano, Manuel Marina Breysse

Number of Employees:

11-50

Last Funding Date:

2023-09-05

IPO Status:

Private

© 2024 MyAiNote.com